A new use for an old drug provides dual glucose and LDL-lowering therapy in the modern setting of T2D management: Colesevelam HCL

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)331-332
Number of pages2
JournalCurrent Diabetes Reports
Issue number5
StatePublished - Oct 13 2009

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this